{"transactions":[{"id":3686833,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":160875,"kind":"person","name":"Quiroz Jorge Armando","position":1,"cik":"0001727401","reported_name":"Quiroz Jorge Armando","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-25T22:08:26.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 23, 2019 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":60000,"derivative":{"exercise_price":22.93,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-19-001960","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319001960/doc4.xml","form_type":"4"}},{"id":3743850,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":160875,"kind":"person","name":"Quiroz Jorge Armando","position":1,"cik":"0001727401","reported_name":"Quiroz Jorge Armando","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-05T00:01:41.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":1370,"price":32.2441,"value":44174.417,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.56, inclusive. The reporting person undertakes to provide to the issuer, any\nsecurity holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form."}],"balance_after":228092,"source":{"system":"sec-edgar","filing":"0000899243-18-030087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/doc4.xml","form_type":"4"}},{"id":3743849,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":160875,"kind":"person","name":"Quiroz Jorge Armando","position":1,"cik":"0001727401","reported_name":"Quiroz Jorge Armando","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-05T00:01:41.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":31426,"price":31.4118,"value":987147.2268,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.01 to $31.98, inclusive. The reporting person undertakes to provide to the issuer, any\nsecurity holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form."}],"balance_after":229462,"source":{"system":"sec-edgar","filing":"0000899243-18-030087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/doc4.xml","form_type":"4"}},{"id":3743848,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":160875,"kind":"person","name":"Quiroz Jorge Armando","position":1,"cik":"0001727401","reported_name":"Quiroz Jorge Armando","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-05T00:01:41.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":6154,"price":30.208,"value":185900.032,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.97, inclusive. The reporting person undertakes to provide to the issuer, any\nsecurity holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form."}],"balance_after":260888,"source":{"system":"sec-edgar","filing":"0000899243-18-030087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/doc4.xml","form_type":"4"}},{"id":3743847,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":160875,"kind":"person","name":"Quiroz Jorge Armando","position":1,"cik":"0001727401","reported_name":"Quiroz Jorge Armando","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-05T00:01:41.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":1200,"price":29.9364,"value":35923.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.90 to $29.99, inclusive. The reporting person undertakes to provide to the issuer, any\nsecurity holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form."}],"balance_after":267042,"source":{"system":"sec-edgar","filing":"0000899243-18-030087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/doc4.xml","form_type":"4"}},{"id":3756767,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":160875,"kind":"person","name":"Quiroz Jorge Armando","position":1,"cik":"0001727401","reported_name":"Quiroz Jorge Armando","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-20T11:32:17.000Z","date":"2018-11-16","kind":"sale","acquired":false,"shares":100,"price":34.9,"value":3490.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2018."}],"balance_after":268242,"source":{"system":"sec-edgar","filing":"0000899243-18-029425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318029425/doc4.xml","form_type":"4"}},{"id":4055187,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":160875,"kind":"person","name":"Quiroz Jorge Armando","position":1,"cik":"0001727401","reported_name":"Quiroz Jorge Armando","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-16T01:26:43.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":47061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in four equal installments beginning on February 14, 2019."}],"balance_after":47061,"derivative":{"exercise_price":26.23,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":47061},"source":{"system":"sec-edgar","filing":"0000899243-18-004339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318004339/doc4.xml","form_type":"4"}}]}